| Citation: | SHENG Mei-xiao, JIN Shi, XIONG Pei-hua, JIANG Yan, ZHONG Yu. Therapeutic Effect of Langchuangjing Granule in Treatment of Syndrome of Kidney Deficiency with Damp Toxin in Active Lupus Nephritis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2007, 23(4): 220-223. |
| [1] |
Cheigh JS,Kim H.Systemic lupus erythematosus in paitents with end-stage renal disease:Long-term follow-up on the prognosis of patients and the evolution of lupus activity[J].Am J Kidney Dis,1990,16:189.
|
| [2] |
Hochberg MC.Updating the American College of Rheumatologyrevised criteria for the classification of SLE[J].Arthritis Rheum,1997,40:1725.
|
| [3] |
Claire Bombardier,Dafna D.Giadman,Murray B.Umwitz et al.Derivation f the SLEDAI[J].Arthrotis and Rheumatism,1997,35(6):630.
|
| [4] |
邹万忠.肾脏病理与临床[M].长沙:湖南科学技术出版社,1997.55.
|
| [5] |
郑筱萸.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002.219.
|
| [6] |
沈庆法.中医临床肾脏病学[M].上海:上海科学技术文献出版社,1997.452.
|
| [7] |
中国中西医结合肾病专业委员会.弥漫增生型狼疮肾炎中西医结合诊治标准[S].中国中西医结合肾病杂志,2002,3(4):189.
|
| [8] |
盛梅笑,王钢,王胜菊.狼疮性肾炎中医证候学特征的临床回顾性分析[J].辽宁中医杂志,2004,31(6):475.
|
| [9] |
王敏,董怡,黄尚东.肿瘤坏死因子α基因多态性及其与系统性红斑狼疮的相关性[J].中华内科杂志,1999,38(3):393.
|
| [10] |
蔡后荣,张杏书,刘布骏,等.血清可溶性IL-2R检测在结缔组织病中的应用[J].上海免疫学杂志,1993,13(4):216.
|
| [11] |
杨利,金实,汪悦,等.狼疮静颗粒对活动性SLE患者血清sIL-2R、TNF-α的影响[J].中国中医药信息杂志,2000,7(9):37.
|